Stéphane Séjourné, a 39-year-old confidant of French President Emmanuel Macron and the European Union’s new industry czar. He ...

32 per equity share for the year. This dividend for the year ended 31 March 2024 is subject to the approval of Members at the Annual General Meeting on 28 June 2024 and will be paid on or after 1 ...

The Quarterly Results page of SmithKline Beecham Pharmaceuticals Ltd.[Merged] presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results.

GlaxoSmithKline Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 13/11/1924 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification ...

1 Day SANN -3.04% DJIA -1.01% Russell 2K -0.91% Health Care/Life Sciences -0.28% ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Medical ...

Stock Market Dropped On February 21; Is Trump's New Tariff Threat The Reason Why Sensex, Nifty Falling? Stock Market Outlook For February 21: Will Sensex, Nifty Rise Or Fall On Friday? Stock ...

Shares of GlaxoSmithKline Pharmaceuticals (GSK Pharma) extended their rally for the second consecutive session on Tuesday (February 18), gaining 29% over two days. The stock had hit a 20% upper ...

Today, a brief rundown of news involving Sanofi and Supernus Pharmaceuticals, as well as updates from Arcus Biosciences, Gilead Sciences and Ultragenyx Pharmaceutical that you might have missed.

On the 14th, the FDA approved a product license for Merilog, an insulin biosimilar from the French pharmaceutical company Sanofi. Merilog is the first product to replicate NovoLog, an insulin ...

But some countries have put restrictions on French imports as a result - concerned that vaccinated birds pose a risk as they may not show signs of infection, meaning it is impossible to determine ...

GlaxoSmithKline Pharmaceuticals' shares surged nearly 16% as net profit rose over five-fold to Rs 229 crore for Q3 2024. The stock reached Rs 2,332.25 on BSE and Rs 2,339 on NSE. Revenue increased to ...